brexucabtagene autoleucel,Blinatumomab,Inotuzumab
gilead,astellas,amgen,pfizer,UCB Pharmaceuticals
['zuma-3']
live at #ash22! dr. bijal d. shah of discusses updated outcomes from historical control study scholar-3 contextualizing zuma-3 results of brexucatagene autoleucel. read more 
The official account of Moffitt Cancer Center. Our mission: to contribute to the prevention and cure of cancer. News and stories at https://t.co/XaP6iv4q19.